Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

This study has been completed.

Study NCT00054340 Information provided by Fred Hutchinson Cancer Research Center

First Received: February 5, 2003 Last Updated: May 12, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given